164 related articles for article (PubMed ID: 33327875)
1. Sirtuin 2 in Endometrial Cancer: A Potential Regulator for Cell Proliferation, Apoptosis and RAS/ERK Pathway.
Guo Y; Zhao N; Zhou J; Dong J; Wang X
Technol Cancer Res Treat; 2020; 19():1533033820980781. PubMed ID: 33327875
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer.
Zhao N; Guo Y; Liu P; Chen Y; Wang Y
Arch Gynecol Obstet; 2022 Mar; 305(3):693-701. PubMed ID: 34476599
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.
Ding T; Hao J
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476507
[TBL] [Abstract][Full Text] [Related]
4. IGFBP-rP1 acts as a potential tumor suppressor via the suppression of ERK signaling pathway in endometrial cancer cells.
Ma Y; Jiang J; Zhang Y; Ding Y; Xu T; Lu B
Mol Med Rep; 2017 Aug; 16(2):1445-1450. PubMed ID: 29067463
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
6. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
[TBL] [Abstract][Full Text] [Related]
7. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L
Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
9. SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism.
Li Y; Zhang M; Dorfman RG; Pan Y; Tang D; Xu L; Zhao Z; Zhou Q; Zhou L; Wang Y; Yin Y; Shen S; Kong B; Friess H; Zhao S; Wang L; Zou X
Neoplasia; 2018 Jul; 20(7):745-756. PubMed ID: 29925042
[TBL] [Abstract][Full Text] [Related]
10. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
12. ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.
Tong JS; Zhang QH; Wang ZB; Li S; Yang CR; Fu XQ; Hou Y; Wang ZY; Sheng J; Sun QY
PLoS One; 2010 Nov; 5(11):e15408. PubMed ID: 21079811
[TBL] [Abstract][Full Text] [Related]
13. Restoration of microRNA-29c in type I endometrioid cancer reduced endometrial cancer cell growth.
Van Sinderen M; Griffiths M; Menkhorst E; Niven K; Dimitriadis E
Oncol Lett; 2019 Sep; 18(3):2684-2693. PubMed ID: 31404303
[TBL] [Abstract][Full Text] [Related]
14. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
[TBL] [Abstract][Full Text] [Related]
15. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K
Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598
[TBL] [Abstract][Full Text] [Related]
16. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
Sun Y; Wang C; Yang H; Ma X
Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
18. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
Zhang S; Wang M; Li Q; Zhu P
Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
[TBL] [Abstract][Full Text] [Related]
19. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
Wang J; Shi H; Xie Y; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
[TBL] [Abstract][Full Text] [Related]
20. Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.
Fan MJ; Liang SM; He PJ; Zhao XB; Li MJ; Geng F
Radiol Oncol; 2019 Sep; 53(3):307-315. PubMed ID: 31553703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
